Apolipoprotein E is Associated with Blood Lipids and Inflammation in Taiwanese Older Adults

Overview

Journal Atherosclerosis

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2011 Aug 16

PMID 21840004

Citations 6

Authors

Sarinnapha Vasunilashorn

Dana A Glei

Chia-Ying Lan

Ron Brookmeyer

Maxine Weinstein

Noreen Goldman

Affiliations

Soon will be listed here.

Abstract

Polymorphisms of the apolipoprotein E gene (ApoE) have been associated with health and longevity. Numerous studies have linked ApoE to health outcomes including cardiovascular disease and mortality, but far fewer studies have examined the relationship of ApoE to other biological markers of health. This study investigates the relationship between ApoE and mortality, as well as ApoE and a set of biomarkers related to cardiovascular and immune function, in a population-based sample of Taiwanese adults ages 54+. ApoE £2 carriers were less likely to have at-risk levels of high-density lipoprotein (HDL-C) and total cholesterol (total-C) than non-carriers (odds ratio [OR] 0.45, 95% confidence interval [CI] 0.25-0.83 and OR 0.45, 95% CI 0.29-0.71, respectively). ApoE £4 carriers were less likely to have elevated levels of C-reactive protein (CRP) than non-carriers (OR 0.62, 95% CI 0.39-0.96). ApoE genotype was not, however, associated with mortality after 8 years of follow-up. Our findings confirm the association between ApoE £2and cholesterol levels, suggesting a potential protective effect of ApoE £2 on blood lipids. They also contribute to reports on the relationship between ApoE £4 carrier status and lower CRP levels.

Citing Articles

Alteration of Blood Immune Biomarkers in MCI Patients with Different Genotypes after Cognitive Training: A 1 Year Follow-Up Cohort Study.

Abramova O, Zorkina Y, Ushakova V, Gryadunov D, Ikonnikova A, Fedoseeva E Int J Mol Sci. 2023; 24(17).

PMID: 37686198 PMC: 10488004. DOI: 10.3390/ijms241713395.

Apolipoprotein E genotype and the association between C-reactive protein and postoperative delirium: Importance of gene-protein interactions.

Vasunilashorn S, Ngo L, Inouye S, Fong T, Jones R, Dillon S Alzheimers Dement. 2019; 16(3):572-580.

PMID: 31761478 PMC: 7086383. DOI: 10.1016/j.jalz.2019.09.080.

The Association between the Apolipoprotein E Gene Polymorphism and All-cause Mortality in the Korean Population.

Choi C, Kweon S, Lee Y, Nam H, Park K, Ryu S J Korean Med Sci. 2019; 34(40):e269.

PMID: 31625294 PMC: 6801224. DOI: 10.3346/jkms.2019.34.e269.

Apolipoprotein E, cognitive function, and cognitive decline among older Taiwanese adults.

Todd M, Schneper L, Vasunilashorn S, Notterman D, Ullman M, Goldman N PLoS One. 2018; 13(10):e0206118.

PMID: 30339707 PMC: 6195295. DOI: 10.1371/journal.pone.0206118.

Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population.

Wu S, Hsu L, Teng M, Lin J, Chou H, Lee M Lipids Health Dis. 2016; 15:94.

PMID: 27177774 PMC: 4866423. DOI: 10.1186/s12944-016-0262-z.

References

Jialal I, Stein D, Balis D, Grundy S, Adams-Huet B, Devaraj S . Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation. 2001; 103(15):1933-5. DOI: 10.1161/01.cir.103.15.1933. View

Pouliot M, Despres J, Moorjani S, Lupien P, Tremblay A, Bouchard C . Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res. 1990; 31(6):1023-9. View

Arvidson N, Gudbjornsson B, Elfman L, Ryden A, Totterman T, Hallgren R . Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 1994; 53(8):521-4. PMC: 1005392. DOI: 10.1136/ard.53.8.521. View

Rontu R, Ojala P, Hervonen A, Goebeler S, Karhunen P, Nikkila M . Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians. Clin Endocrinol (Oxf). 2006; 64(3):265-70. DOI: 10.1111/j.1365-2265.2006.02455.x. View

Bennet A, Prince J, Fei G, Lyrenas L, Huang Y, Wiman B . Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis. 2003; 171(2):359-67. DOI: 10.1016/j.atherosclerosis.2003.08.029. View

Dufouil C, Richard F, Fievet N, Dartigues J, Ritchie K, Tzourio C . APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology. 2005; 64(9):1531-8. DOI: 10.1212/01.WNL.0000160114.42643.31. View

Eichner J, Dunn S, Perveen G, Thompson D, Stewart K, Stroehla B . Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002; 155(6):487-95. DOI: 10.1093/aje/155.6.487. View

Niu W, Guo X, Su Y, Qiu C . Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J Hum Hypertens. 2007; 21(4):337-9. DOI: 10.1038/sj.jhh.1002151. View

Davignon J, GREGG R, Sing C . Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8(1):1-21. DOI: 10.1161/01.atv.8.1.1. View

10.

Weisgraber K, Innerarity T, Mahley R . Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982; 257(5):2518-21. View

11.

Horiuchi S, Coale A . A simple equation for estimating the expectation of life at old ages. Popul Stud (Camb). 2011; 36(2):317-26. DOI: 10.1080/00324728.1982.10409034. View

12.

Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P . A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991; 11(3):298-300, 302. View

13.

Eiriksdottir G, Aspelund T, Bjarnadottir K, Olafsdottir E, Gudnason V, Launer L . Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis. 2006; 186(1):222-4. DOI: 10.1016/j.atherosclerosis.2005.12.012. View

14.

Rebeck G, Kindy M, LaDu M . Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J Alzheimers Dis. 2002; 4(3):145-54. DOI: 10.3233/jad-2002-4304. View

15.

Tan C, Tai E, Tan C, Chia K, Lee J, Chew S . APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis. 2003; 170(2):253-60. DOI: 10.1016/s0021-9150(03)00232-6. View

16.

Olgiati P, Politis A, Malitas P, Albani D, Dusi S, Polito L . APOE epsilon-4 allele and cytokine production in Alzheimer's disease. Int J Geriatr Psychiatry. 2009; 25(4):338-44. DOI: 10.1002/gps.2344. View

17.

Mahley R . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240(4852):622-30. DOI: 10.1126/science.3283935. View

18.

Ewbank D . The APOE gene and differences in life expectancy in Europe. J Gerontol A Biol Sci Med Sci. 2004; 59(1):16-20. DOI: 10.1093/gerona/59.1.b16. View

19.

Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G . Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261(5123):921-3. DOI: 10.1126/science.8346443. View

20.

Schachter F, Guenot F, Rouger H, Froguel P, Cohen D . Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994; 6(1):29-32. DOI: 10.1038/ng0194-29. View